Amitriptyline Hydrochloride

DRUG5 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), McGill University Health Centre/Research Institute of the McGill University Health Centre, Gil Yosipovitch, AlgoTherapeutix

Conditions

ErythromelalgiaFibromyalgiaHIV InfectionsPeripheral Nervous System DiseasePruritusSleep Initiation and Maintenance Disorders

Phase 2

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

CompletedNCT00000793

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Peripheral Nervous System Disease

End: 1997-10-31Target: 240Updated: 2021-10-29

Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine

TerminatedNCT03096444

Gil YosipovitchPruritus

Start: 2017-05-23End: 2017-07-21Updated: 2019-07-02

EASE (Efficacy of ATX01 Study in Erythromelalgia)

CompletedNCT05917912

AlgoTherapeutixErythromelalgia

Start: 2023-06-14End: 2024-02-29Updated: 2024-04-18

Unknown Phase

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

CompletedNCT00000817

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Peripheral Nervous System Disease

Start: 1994-11-30End: 1997-05-31Updated: 2021-11-03

Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia

CompletedNCT00381199

McGill University Health Centre/Research Institute of the McGill University Health CentreFibromyalgia, Sleep Initiation and Maintenance Disorders

Start: 2006-04-30End: 2007-03-31Updated: 2007-05-21